Alex Virgilio

Balyasny Asset Management LP (BAM) is a multi-strategy hedge fund manager and SEC-registered investment advisor headquartered in Chicago, Illinois. The firm’s predecessor, Balyasny Capital Management LLC (BCM), was founded in 2001 by Dmitry Balyasny, Scott Schroeder and Taylor O'Malley. In 2003, BCM converted from a limited liability company to a limited partnership. Then, in January 2004, their name was changed to Balyasny Asset Management LP. They are a subsidiary of Balyasny Asset Management Holdings LP. BAM provides investment advisory services to high net-worth individuals and institutional clients through privately offered pooled investment funds.

Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.

PFM Health Sciences LP (PFM) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Chris James in 2004 as Partner Fund Management LP. PFM serves as an investment advisor to private investment funds in which qualified investors invest directly.

Founded in 2012, Asymmetry Capital Management is a registered investment advisor and hedge fund manager located in San Francisco, California. Scott C. Kay is the founder, principal owner and CIO of the firm. Mr. Kay is also the manager of the firm’s general partner, curis cognitio LLC, and the manager of ACM HC, LLC, the firm's sole limited partner. Asymmetry provides investment management services primarily to private investment funds, which are offered exclusively to sophisticated investors. The Firm also provides investment management services to other private funds or sophisticated investors on a discretionary basis through separately managed accounts.